Perseon Corporation Announces First Quarter Fiscal Year 2015 Conference Call
April 20 2015 - 9:15AM
Perseon Corporation (Nasdaq:PRSN) (Perseon of the Company), a
leading provider of medical systems that utilize heat therapy to
treat cancer, today announced plans to release its financial
results for the first quarter ended March 31, 2015 before the
market opens on Thursday, May 14, 2015. The Company will host a
corresponding conference call with a live webcast later that day at
2:00 p.m. Eastern Time/12:00 p.m. Mountain Time.
Individuals interested in listening to the conference call may
do so by visiting the Investor Relations section of the Company's
website at www.perseonmedical.com or by dialing 800.860.2442 from
the United States, or 412.858.4600 from outside the United States,
and referencing "Perseon Corporation." We request that you RSVP to
the conference call by emailing tross@finprofiles.com before 4:00
p.m. Eastern time on Tuesday, May 12, 2015.
A telephone replay will be available through May 21, 2015, by
dialing 877.344.7529 from the United States, or 412.317.0088 from
outside the United States, and entering conference ID 10064204. A
webcast replay will be available for 90 days.
About Perseon
Perseon Corporation, formerly BSD Medical Corporation, invests
its resources in fighting humanity's worst disease: cancer.
Perseon's people are dedicated to finding innovative technologies
and means to deliver microwave ablation solutions to healthcare
providers and patients around the world. MicroThermX® treats soft
tissue tumors with precision-focused microwave energy, expanding
the options and broadening the opportunities for cancer
treatment.
Forward-Looking Statements
Statements contained in this press release that are not
historical facts, including statements relating to our intent to
divest our hyperthermia business in Spring 2015, focus on microwave
ablation to create stockholder value, comply with Nasdaq continued
listing requirements, generate capital from a transaction related
to our building and pursue other strategic plans are
forward-looking statements, as defined in the Private Securities
Litigation Reform Act of 1995. All forward-looking statements are
subject to risks and uncertainties, including the risk that for a
variety of reasons we may not be able to execute on our strategic
plans, and other risks and uncertainties detailed in the Company's
filings with the Securities and Exchange Commission. These
forward-looking statements speak only as of the date on which such
statements are made, and the Company undertakes no obligation to
update such statements to reflect events or circumstances arising
after such date, except as required by law.
CONTACT: Tricia Ross
Financial Profiles
310-622-8226
tross@finprofiles.com